AAAAAA
Results:
1-14
|
Results: 14
Authors:
Caprioli, F
Pometta, R
Visentin, S
Massironi, S
Conte, D
Citation: F. Caprioli et al., "Hepatitic flare", asthenia, peripheral polyneuropathy and diffuse liver steatosis in a hepatitis C virus asymptomatic chronic carrier, DIG LIVER D, 33(4), 2001, pp. 359-362
Authors:
Visentin, S
Renzi, M
Levi, G
Citation: S. Visentin et al., Altered outward-rectifying K+ current reveals microglial activation induced by HIV-1 Tat protein, GLIA, 33(3), 2001, pp. 181-190
Authors:
Graham, ID
Beardall, S
Carter, AO
Glennie, J
Hebert, PC
Tetroe, JM
McAlister, FA
Visentin, S
Anderson, GM
Citation: Id. Graham et al., What is the quality of drug therapy clinical practice guidelines in Canada?, CAN MED A J, 165(2), 2001, pp. 157-163
Authors:
Boschi, D
Caron, G
Visentin, S
Di Stilo, A
Rolando, B
Fruttero, R
Gasco, A
Citation: D. Boschi et al., Searching for balanced hybrid NO-donor 1,4-dihydropyridines with basic properties, PHARM RES, 18(7), 2001, pp. 987-991
Authors:
Cena, C
Visentin, S
Di Stilo, A
Boschi, D
Fruttero, R
Gasco, A
Citation: C. Cena et al., Studies on agents with mixed NO-dependent and calcium channel antagonisticvasodilating activities, PHARM RES, 18(2), 2001, pp. 157-165
Authors:
Visentin, S
Ermondi, G
Boschi, D
Grosa, G
Fruttero, R
Gasco, A
Citation: S. Visentin et al., Thermolysis of 4-(2-azido-3-nitrophenyl)-1,4-dihydropyridines as source ofbeta-carboline derivatives and some related compounds, TETRAHEDR L, 42(27), 2001, pp. 4507-4510
Authors:
Colli, A
Fraquelli, M
Pometta, R
Cocciolo, M
Visentin, S
Conte, D
Citation: A. Colli et al., Renovascular impedance and esophageal varices in patients with Child-Pugh class A cirrhosis, RADIOLOGY, 219(3), 2001, pp. 712-715
Authors:
Fraquelli, M
Losco, A
Visentin, S
Cesana, BM
Pometta, R
Colli, A
Conte, D
Citation: M. Fraquelli et al., Gallstone disease and related risk factors in patients with Crohn disease - Analysis of 330 consecutive cases, ARCH IN MED, 161(18), 2001, pp. 2201-2204
Authors:
Ermondi, G
Visentin, S
Boschi, D
Fruttero, R
Gasco, A
Citation: G. Ermondi et al., Structural investigation of Ca2+ antagonists benzofurazanyl and benzofuroxanyl-1,4-dihydropyridines, J MOL STRUC, 523, 2000, pp. 149-162
Authors:
Visentin, S
Amiel, P
Gasco, A
Bonnet, B
Suteu, C
Roussel, C
Citation: S. Visentin et al., Resolution of some 4-benzofurazanyl and 4-benzofuroxanyl 1,4-dihydropyridine derivatives by chiral HPLC on Whelk-O1 and some polysaccharide chiral stationary phases, CHIRALITY, 11(7), 1999, pp. 602-608
Authors:
Medana, C
Di Stilo, A
Visentin, S
Fruttero, R
Gasco, A
Ghigo, D
Bosia, A
Citation: C. Medana et al., NO donor and biological properties of different benzofuroxans, PHARM RES, 16(6), 1999, pp. 956-960
Authors:
Visentin, S
Renzi, M
Frank, C
Greco, A
Levi, G
Citation: S. Visentin et al., Two different ionotropic receptors are activated by ATP in rat microglia, J PHYSL LON, 519(3), 1999, pp. 723-736
Authors:
Visentin, S
Amiel, P
Fruttero, R
Boschi, D
Roussel, C
Giusta, L
Carbone, E
Gasco, A
Citation: S. Visentin et al., Synthesis and voltage-clamp studies of methyl 1,4-dihydro-2,6-dimethyl-5-nitro-4-(benzofurazanyl)pyridine-3-carboxylate racemates and enantiomers andof their benzofuroxanyl analogues, J MED CHEM, 42(8), 1999, pp. 1422-1427
Authors:
Di Stilo, A
Visentin, S
Cena, C
Gasco, AM
Ermondi, G
Gasco, A
Citation: A. Di Stilo et al., New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities, J MED CHEM, 41(27), 1998, pp. 5393-5401
Risultati:
1-14
|